ACL » Topics » Cash Flows

This excerpt taken from the ACL 6-K filed Jul 24, 2008.

Cash Flows

 

During the six months ended June 30, 2008, the Company generated operating cash flow of $1,072.0 million, primarily from net earnings, compared to $346.7 million in the same period of 2007. In 2007, $520.8 million of cash was used to purchase trading securities, which reduced operating cash flow in that period. In 2008 and 2007, a portion of the operating cash flow was used to pay dividends to common shareholders, as discussed under "Financing Activities," and for investing activities.

 

This excerpt taken from the ACL 6-K filed Apr 24, 2008.

Cash Flows

 

During the three months ended March 31, 2008, the Company generated operating cash flow of $398.1 million, primarily from net earnings. A portion of the operating cash flow was used to purchase Alcon common shares, as discussed under "Financing Activities," and for investing activities.

 

This excerpt taken from the ACL 20-F filed Mar 18, 2008.

Cash Flows

 

During the year ended December 31, 2007, the Company generated operating cash flow of $1,469.5 million, compared to $1,405.9 million in 2006. The increase reflected the Company's 17.7% net earnings improvement in 2007 that was partially offset by its investment of $405.1 million in trading securities, which decreased operating cash flow. In the year ended December 31, 2005, cash provided by operating activities included $110.1 million for tax benefits from share-based arrangements. In the years ended December 31, 2007 and 2006, the tax benefits from share-based arrangements of $95.2 million and $96.1 million, respectively, were included in cash provided by (used in) financing activities in accordance with the adoption of SFAS No. 123(R).

 

A portion of the operating cash flow was used for payment of dividends on common shares, for the purchase of Alcon common shares and for capital expenditures, including improvements and upgrades to our manufacturing plants and certain other facilities.

 

This excerpt taken from the ACL 6-K filed Oct 25, 2007.

Cash Flows

 

During the nine months ended September 30, 2007, the Company generated operating cash flow of $814.7 million, compared to $914.9 million for the same period of 2006. The decrease reflected the company's investment of $539.3 million during 2007 in trading securities, which decreased operating cash flow.

 

 

28

 

 

This excerpt taken from the ACL 6-K filed Jul 26, 2007.

Cash Flows

 

During the six months ended June 30, 2007, the Company generated operating cash flow of $346.7 million, compared to $747.7 million for the same period of 2006. The decrease reflected the company's investment of $527.5 million during 2007 in trading securities, which decreased operating cash flow.

 

This excerpt taken from the ACL 6-K filed Apr 26, 2007.

Cash Flows

 

During the three months ended March 31, 2007, the Company generated operating cash flow of $342.9 million. A portion of the operating cash flow was used for the purchase of Alcon common shares, as discussed under "Financing Activities."

 

This excerpt taken from the ACL 20-F filed Mar 19, 2007.

Cash Flows

 

During the year ended December 31, 2006, the Company generated operating cash flow of $1,405.9 million, after payment of $121.0 million to settle patent litigation in July 2006. In the years ended December 31, 2005 and 2004, cash provided by operating activities included $110.1 million and $9.3 million, respectively, for tax benefits from share-based arrangements. In 2006, the tax benefits from share-based arrangements of $96.1 million were included in cash provided by (used in) financing activities in accordance with the adoption of SFAS No. 123(R).

 

A portion of the operating cash flow was used for payment of dividends on common shares, for the purchase of Alcon common shares and for capital expenditures, including improvements and upgrades to our manufacturing plants and certain other facilities.

 

This excerpt taken from the ACL 6-K filed Oct 24, 2006.

Cash Flows

 

During the nine months ended September 30, 2006, the Company generated operating cash flow of $914.7 million, after payment of $121.0 million to settle patent litigation in July 2006. In the nine months ended September 30, 2005, cash provided by operating activities included $81.0 million for tax benefits from share-based arrangements. In 2006, the tax benefits from share-based arrangements of $80.5 million were included in cash provided by (used in) financing activities in accordance with the adoption of SFAS No. 123(R).

 

A portion of the operating cash flow was used for payment of dividends on common shares, the purchase of Alcon common shares, as discussed under "Financing Activities," and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

 

31

 

 

This excerpt taken from the ACL 6-K filed Jul 25, 2006.

Cash Flows

 

During the six months ended June 30, 2006, the Company generated operating cash flow of $747.7 million. A portion of the operating cash flow was used for payment of dividends on common shares, the purchase of Alcon common shares, as discussed under "Financing Activities," and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

 

In the six months ended June 30, 2005, cash provided by operating activities included $68.2 million for tax benefits from share-based arrangements. In 2006, the tax benefits from share-based arrangements of $49.0 million were included in cash provided by (used in) financing activities in accordance with the adoption of SFAS No. 123(R).

 

This excerpt taken from the ACL 6-K filed Apr 25, 2006.

Cash Flows

 

During the three months ended March 31, 2006, the Company generated operating cash flow of $267.6 million. A portion of the operating cash flow was used for the purchase of Alcon common shares, as discussed under "Financing Activities," and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

 

In the three months ended March 31, 2005, cash provided by operating activities included $31.9 million for tax benefits from share-based arrangements. In 2006, the tax benefits from share-based arrangements of $34.4 million were included in cash provided by (used in) financing activities in accordance with the adoption of SFAS No. 123(R).

 

This excerpt taken from the ACL 20-F filed Mar 15, 2006.

Cash Flows

 

During the year ended December 31, 2005, the Company generated operating cash flow of $1,235.0 million. Most of the operating cash flow was used for the purchase of Alcon common shares, for dividends on common shares as discussed under "Financing Activities," and for purchases of available-for-sale investments and capital expenditures, including improvements in our manufacturing facilities and research and development facilities.

 

This excerpt taken from the ACL 6-K filed Oct 20, 2005.

Cash Flows

 

During the nine months ended September 30, 2005, the Company generated operating cash flow of $1,073.1 million. A significant portion of the operating cash flow was used for payment of dividends on common shares, for the purchase of Alcon common shares, as discussed under “Financing Activities,” and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

 

This excerpt taken from the ACL 6-K filed Jul 28, 2005.

Cash Flows

 

During the six months ended June 30, 2005, the Company generated operating cash flow of $653.5 million. A significant portion of the operating cash flow was used for payment of dividends on common shares, for the purchase of Alcon common shares, as discussed under “Financing Activities,” and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

 

This excerpt taken from the ACL 6-K filed Apr 22, 2005.

Cash Flows

 

During the three months ended March 31, 2005, the Company generated operating cash flow of $266.4 million. A portion of the operating cash flow was used for the purchase of Alcon common shares, as discussed under “Financing Activities,” and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

 

This excerpt taken from the ACL 20-F filed Mar 15, 2005.

Cash Flows

        During the year ended December 31, 2004, the Company generated operating cash flow of $1,047.8 million. Most of the operating cash flow was used for repayment of short term borrowings, for the purchase of Alcon common shares, for dividends on common shares as discussed under “Financing Activities,” and for capital expenditures, including improvements in our manufacturing facilities and certain new construction.

Financing Activities

        During the year ended December 31, 2004, we were able to use over 40% of our cash flows from operations to reduce short term borrowings by $434.5 million. Our short term borrowings are discussed more fully under “Credit and Commercial Paper Facilities” below.

        Since the IPO, the board of directors has approved the purchase of up to 10,000,000 Alcon common shares, including 8,000,000 approved in 2004, to satisfy the exercise of share options granted to employees in 2004 and 2005. Since the IPO, we have purchased 4,401,000 treasury shares (including 3,622,400 treasury shares in 2004) for $278.3 million (including $236.3 million in 2004). We expect to issue new common shares from conditional capital for the exercise of options held by employees that are scheduled to become exercisable in 2005 and 2006.

        The payment of dividends is subject to the availability of retained earnings or dividendable reserves under Swiss law, the proposal by our board of directors, and ultimately the approval of our shareholders. Future dividend payments will depend on various factors, including our net earnings, financial condition, cash requirements, future prospects and other factors deemed relevant by our board of directors in their proposal for approval to the shareholders. Subject to these limitations, we expect to declare a dividend based on 2004 operations of CHF 1.18 per common share, or approximately $1.00 per common share, totaling an estimated $305 million depending on exchange rates. We anticipate that the dividend, if it is approved by the shareholders on May 3, 2005, will be paid on or about May 20, 2005.

53

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki